BY ELAINE WATSON | AgFunderNews
Dutch startup Meatable has acquired the cultivated meat platform of UK-based Uncommon Bio, including key technology, several IP assets, select cell lines, and key staff, for an undisclosed sum.
The move comes as Uncommon Bio pivots away from food, with a message on its website explaining that it has set up a “stealth spin-out in therapeutics” and is looking for scientists to support its new direction, beginning with targeting lung diseases such as idiopathic pulmonary fibrosis.
